Home Newsfeeds Tudor Pickering Upgrades OPAL Fuels to Buy

Tudor Pickering Upgrades OPAL Fuels to Buy

Tudor Pickering analyst Matthew Blair upgrades OPAL Fuels (NASDAQ:OPAL) from Hold to Buy.

byBenzinga Newsdesk

November 18, 2022

1 minute read

Tudor Pickering analyst Matthew Blair upgrades OPAL Fuels (NASDAQ:OPAL) from Hold to Buy.

ThermoGenesis Holdings Q2 EPS $(0.20) Up From $(0.38) YoY

By Benzinga Newsdesk

August 11, 2:42 PM

ThermoGenesis Holdings (NASDAQ:THMO) reported quarterly losses of $(0.20) per share. This is a 47.37 percent increase over losses of $(0.38) per share from the same period last year.

THMO

Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical

By Vandana Singh

February 14, 8:59 AM

Fusion Pharmaceuticals Inc (NASDAQ:FUSN) acquired the investigational new drug application for an ongoing Phase 2 TATCIST trial evaluating 225Ac-PSMA…

FUSN

World Health Organization Updates Emergency Use Listing For Novavax Nuvaxovid COVID-19 Vaccine As A Primary Series In Adolescents And As A Booster In Adults

By Benzinga Newsdesk

November 29, 9:49 AM

Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization (WHO) has

NVAX

What’s Going On With Danish Healthcare Firm Genmab Stock?

By Vandana Singh

January 23, 2:11 PM

Genmab's legal update on Darzalex: Arbitrator dismisses bid for milestone payments. Despite this, diverse revenue sources, including royalty agreements, contribute to strong growth.

GMAB

Tudor Pickering Upgrades OPAL Fuels to Buy

Related Posts

ThermoGenesis Holdings Q2 EPS $(0.20) Up From $(0.38) YoY

Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical

World Health Organization Updates Emergency Use Listing For Novavax Nuvaxovid COVID-19 Vaccine As A Primary Series In Adolescents And As A Booster In Adults

What’s Going On With Danish Healthcare Firm Genmab Stock?